Cancidas and Haldol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cancidas (caspofungin acetate) and Haldol (haloperidol). Common drug interactions include bone marrow failure among females and agranulocytosis among males.

The phase IV clinical study analyzes what interactions people have when they take Cancidas and Haldol. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Cancidas?

Cancidas has active ingredients of caspofungin acetate. eHealthMe is studying from 4,879 Cancidas users. Check the latest studies of Cancidas.

What is Haldol?

Haldol has active ingredients of haloperidol. It is often used in schizophrenia. eHealthMe is studying from 23,102 Haldol users. Check the latest studies of Haldol.



On Aug, 12, 2026

24 people who take Cancidas and Haldol together, and have interactions are studied.

Cancidas and Haldol drug interactions.

What are the common drug interactions of Cancidas and Haldol, by gender? *:

female:

  1. Bone marrow failure
  2. Renal failure (kidney dysfunction)
  3. Sepsis (a severe blood infection that can lead to organ failure and death)
  4. Bacterial pyelonephritis (bacterial kidney infection)
  5. Cerebral haemorrhage (bleeding within the brain)
  6. Coagulopathy (blood's ability to clot is impaired)
  7. Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
  8. Haemolytic uraemic syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more)
  9. Leukaemia recurrent (repeat cancer of bone marrow or blood cells)
  10. Rash

male:

  1. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  2. Toxic skin eruption (skin breakdown due to toxic substance)
  3. Coma (state of unconsciousness lasting more than six hours)
  4. Depressed level of consciousness
  5. Echolalia (meaningless repetition of another person's spoken words -psychiatric disorder)
  6. Febrile neutropenia (fever with reduced white blood cells)
  7. Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
  8. Hypertension (high blood pressure)
  9. Irritability
  10. Nystagmus (a condition of involuntary eye movement)

What are the common drug interactions of Cancidas and Haldol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Abdominal pain
  2. Agitation (state of anxiety or nervous excitement)
  3. Amaurosis (partial or total blindness without visible change in the eye)
  4. Aphasia (damage to the parts of the brain that control language)
  5. Ataxia (loss of full control of bodily movements)
  6. Coma (state of unconsciousness lasting more than six hours)
  7. Depressed level of consciousness
  8. Echolalia (meaningless repetition of another person's spoken words -psychiatric disorder)
  9. Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
  10. Hypertension (high blood pressure)

10-19:

  1. Escherichia test positive
  2. Hallucination, auditory (perceiving sounds without auditory stimulus)
  3. Hallucination, visual (seeing things that aren't there)
  4. Hypotension (abnormally low blood pressure)
  5. Neutropenia (an abnormally low number of neutrophils)
  6. Pyrexia (fever)
  7. Tachycardia (a heart rate that exceeds the range of 100 beats/min)

20-29:

n/a

30-39:

  1. Bone marrow failure
  2. Bacterial pyelonephritis (bacterial kidney infection)
  3. Cerebral haemorrhage (bleeding within the brain)
  4. Coagulopathy (blood's ability to clot is impaired)
  5. Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
  6. Haemolytic uraemic syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more)
  7. Leukaemia recurrent (repeat cancer of bone marrow or blood cells)
  8. Rash
  9. Renal failure (kidney dysfunction)
  10. Sepsis (a severe blood infection that can lead to organ failure and death)

40-49:

n/a

50-59:

  1. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  2. Toxic skin eruption (skin breakdown due to toxic substance)
  3. Acute lymphocytic leukaemia (cancer of the white blood cells)
  4. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  5. Haematocrit decreased
  6. Haemodynamic instability (disturbances in the blood movement in our body)
  7. Haemoglobin decreased
  8. Lower gastrointestinal haemorrhage (bleeding in the large intestine, rectum, or anus is called lower gi bleeding)

60+:

  1. Renal failure (kidney dysfunction)
  2. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  3. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  4. Hepatic congestion (liver congestion)
  5. Hepatic failure (liver failure)
  6. Hepatic necrosis (large portions of liver die off due to severe liver disease)
  7. Hepatotoxicity (chemical-driven liver damage)
  8. Platelet count decreased
  9. Pneumonia adenoviral (viral pneumonia caused by an adenovirus)
  10. Pulmonary haemorrhage (acute bleeding from the lung)

What are the existing conditions these people have? *

  1. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 6 people, 25.00%
  2. Haemolytic Uraemic Syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more): 6 people, 25.00%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 25.00%
  4. Cystitis Escherichia (inflammation of the wall of the bladder by bacteria escherichia coli): 6 people, 25.00%
  5. Cytomegalovirus Infection: 6 people, 25.00%
  6. Gastrointestinal Candidiasis (fungal infection of gastrointestinal tract): 6 people, 25.00%
  7. Infection: 5 people, 20.83%
  8. Pain: 4 people, 16.67%
  9. Stress And Anxiety: 3 people, 12.50%
  10. Fungal Infection: 3 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Cancidas and Haldol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cancidas and Haldol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cancidas:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Haldol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cancidas and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Haldol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on caspofungin acetate and haloperidol (the active ingredients of Cancidas and Haldol, respectively), and Cancidas and Haldol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: